Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XinRay Systems is a medical technology company specializing in the development of advanced X-ray imaging systems based on carbon nanotube (CNT) field emission technology. Founded as a joint venture between Xintek and Rayence, the company focuses on creating high-resolution, multi-beam X-ray sources that eliminate the need for mechanical motion in tomographic imaging. Their product portfolio includes solutions for digital breast tomosynthesis, dental imaging, and security screening. By leveraging nanotechnology, XinRay aims to improve diagnostic accuracy while reducing system complexity and footprint. The company's proprietary CNT cold cathode technology allows for rapid switching and precise control of X-ray exposure, enabling faster and clearer diagnostic imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XinRay Systems.